TransMedics Group, Inc. (BIT:1TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	3,147	1,804	2,219	1,707	458	465
Market Cap Growth	-29.02%	-18.72%	29.99%	272.55%	-1.54%	37.32%
Enterprise Value	3,248	1,958	2,322	1,591	416.38	387.1
PE Ratio	51.57	61.73	-102.51	-50.18	-11.97	-17.16
Forward PE	42.12	56.70	-	-	-	-
PS Ratio	6.96	4.75	10.67	21.23	17.60	21.09
PB Ratio	11.62	9.17	18.79	10.59	7.85	5.21
P/TBV Ratio	11.54	9.61	18.71	9.74	7.80	4.73
P/FCF Ratio	212.96	-25.90	-15.64	-34.37	-16.44	-17.60
P/OCF Ratio	32.06	42.95	-197.94	-43.30	-18.45	-17.87
EV/Sales Ratio	7.11	5.15	11.17	19.78	15.99	17.54
EV/EBITDA Ratio	35.32	39.74	-131.28	-66.12	-12.86	-18.13
EV/EBIT Ratio	49.31	60.67	-93.91	-58.81	-12.27	-17.05
EV/FCF Ratio	219.85	-28.11	-16.36	-32.03	-14.94	-14.64
Debt / Equity Ratio	1.62	2.26	3.75	0.35	0.65	0.33
Debt / EBITDA Ratio	5.17	9.05	-25.11	-2.42	-1.16	-1.40
Debt / FCF Ratio	29.90	-6.40	-3.13	-1.17	-1.35	-1.13
Asset Turnover	0.63	0.58	0.49	0.45	0.21	0.20
Inventory Turnover	5.00	3.95	2.70	1.59	0.68	0.78
Quick Ratio	8.93	7.25	8.34	9.67	4.23	11.15
Current Ratio	9.86	8.30	9.30	10.66	5.11	12.36
Return on Equity (ROE)	26.22%	19.39%	-15.42%	-28.39%	-51.49%	-36.27%
Return on Assets (ROA)	8.74%	4.92%	-5.48%	-15.29%	-27.51%	-20.53%
Return on Capital (ROIC)	15.80%	9.84%	-14.53%	-58.10%	-129.45%	-124.18%
Return on Capital Employed (ROCE)	9.71%	5.37%	-6.35%	-17.22%	-31.32%	-23.01%
Earnings Yield	1.94%	1.62%	-0.98%	-1.99%	-8.35%	-5.83%
FCF Yield	0.47%	-3.86%	-6.39%	-2.91%	-6.08%	-5.68%
Buyback Yield / Dilution	-0.36%	-1.09%	-0.28%	-7.33%	-0.26%	-13.97%
Total Shareholder Return	-	-1.09%	-0.28%	-7.33%	-0.26%	-13.97%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.